1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Immunic, Inc.

Immunic, Inc.

IMUX
Immunic, Inc.US flagNASDAQ Global Select
6.96
USD
-0.03
- -
94.97MMarket Cap

Total Valuation

Immunic, Inc. carries a market capitalization of 94.97M, placing it among publicly traded companies globally. Its enterprise value stands at 55.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap94.97M
Enterprise Value55.18M

Share Statistics

Immunic, Inc. currently has 13.64M shares outstanding.

Shares Outstanding13.64M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio1.64
P/TBV Ratio1.64
P/FCF Ratio-5.40
P/OCF Ratio-5.38

Financial Position

Immunic, Inc. maintains a current ratio of 5.05, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

Current Ratio5.05
Quick Ratio4.97
Debt / Equity0.44
Debt / EBITDA0.00
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)-138.17
Return on Assets (ROA)-101.15
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Immunic, Inc.'s stock has declined approximately -16.74641% over the past 52 weeks. The 50-day moving average sits at 11.77, while the 200-day moving average is 11.45.

Beta (5Y)N/A
52-Week Price Change-16.74641%
50-Day Moving Average11.77
200-Day Moving Average11.45
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -117.73M, while operating income came in at -117.88M.

RevenueN/A
Gross ProfitN/A
Operating Income-117.88M
Pretax Income-111.57M
Net Income-111.57M
EBITDA-117.73M
EBIT-117.88M
Earnings Per Share (EPS)-3.64

Balance Sheet

Immunic, Inc. holds 155.10M in cash and equivalents against 567,000.00 in total debt, resulting in a net debt position of -155.10M. Total book value stands at 127.58M, with working capital of 126.57M providing operational flexibility.

Cash & Cash Equivalents155.10M
Total Debt567,000.00
Net Debt-155.10M
Equity (Book Value)127.58M
Book Value Per Share9.35
Working Capital126.57M

Cash Flow

Immunic, Inc. produced -87.72M in operating cash flow over the past twelve months. After subtracting -329,000.00 in capital expenditures, free cash flow totaled -88.05M - equivalent to -2.87 per share.

Operating Cash Flow-87.72M
Capital Expenditures-329,000.00
Free Cash Flow-88.05M
FCF Per Share-2.87

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-90.04
FCF Yield-18.53

Stock Splits

Immunic, Inc.'s most recent stock split took place on April 27, 2026 with a 10:1 split ratio.

Last Split Date4/27/2026
Split Ratio10:1

Scores

Immunic, Inc. posts an Altman Z-Score of -3.45, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.45